Imported wheat-seed extract for nutraceuticals: vegetable extract CTH 1302 or food preparation CTH 2106-classified under 2106 90 99

The dominant issue was whether an imported wheat-seed extract product ("wheat seed oil, ceramosides") used in nutraceuticals was classifiable as a vegetable extract under CTH 1302 or as a food preparation under CTH 2106. Applying the tariff description and intended use, the AAR found the goods were obtained by solvent extraction and subsequent filtration, evaporation and concentration, were standardised to deliver defined functional lipids, licensed as a functional ingredient for dietary supplements, and marketed for general wellbeing (skin and hair health) rather than disease treatment or prevention. On this basis, it was held to be a food/nutraceutical preparation falling within Heading 2106, and classified under CTH 2106 90 99.

---

---

1. ISSUES PRESENTED AND CONSIDERED

(i) Whether "Wheat Seed Oil - Ceramosides" is classifiable as a "vegetable sap or extract" under Tariff Heading 1302 (specifically 13021919), having regard to its method of manufacture, degree of processing/standardisation, physical form, and described use.

(ii) If not classifiable under Heading 1302, whether the product is classifiable as a "food preparation not elsewhere specified or included" under Heading 2106 (specifically 21069099) as a nutraceutical/food supplement preparation based on plant extract with defined functional characteristics and dosage-linked use.

2. ISSUE-WISE DETAILED ANALYSIS

Issue (i): Classification under Heading 1302 (vegetable saps and extracts)

Legal framework (as applied by the Court): The Court applied the General Rules for Interpretation, particularly GRI 1, requiring classification by the terms of the headings and relevant Section/Chapter Notes, and considered the scope-limiting conditions reflected in the HSN explanatory guidance discussed in the ruling for Heading 1302 (i.e., coverage of simple solvent extracts and exclusion where processing/standardisation moves the product beyond a crude extract).

Interpretation and reasoning: On the materials and technical literature, the Court found the product is obtained by solvent-driven extraction from wheat seed/wheat flour using ethanol under controlled conditions, followed by liquid fraction/filtration and then evaporation and concentration steps, yielding a final product marketed as Ceramosides. The Court treated these steps-together with the product's marketed nutraceutical identity, clinical support, and dosage indication (including that it "can be taken directly" in oil form)-as demonstrating a prepared/standardised product rather than a crude/simple vegetable extract. The Court additionally reasoned that the product's character as a 100% oil/fat/lipid preparation with a specific dietary supplement use did not match the ordinary contemplation of vegetable saps/extracts under Heading 1302 as discussed in the ruling.

Conclusion: The Court conclusively held that Heading 1302 is not applicable and rejected classification under Tariff Item 13021919.

Issue (ii): Classification under Heading 2106 (food preparations not elsewhere specified or included)

Legal framework (as applied by the Court): The Court examined Heading 2106 in light of the HSN note discussed in the ruling that includes preparations referred to as food/dietary supplements consisting of or based on extracts/isolates found in foods, and applied GRI 1 (and, additionally, considered GRI 3(b) on "essential character" as supporting this classification).

Interpretation and reasoning: The Court found the product's "functional characteristics," structured concentration achieved through fractionation/filtration and concentration, and its nutraceutical end-use as an ingredient for oral consumption through dietary supplements align with Heading 2106. The Court relied on the product literature endorsing nutraceutical/dietary supplement positioning and benefits relating to general skin and hair well-being and appearance, and noted the absence (on the Court's findings) of therapeutic/prophylactic character necessary for classification as medicaments. The Court also treated trade/commercial identity and intended use as determinative: the product is a standardised functional ingredient, not a raw plant extract for industrial or non-food uses.

Conclusion: The Court conclusively held that the product has the essential character of a food/nutraceutical preparation based on plant extract and is classifiable under CTH 2106 90 99. The ruling answers "No" to Heading 1302 and "Yes" to Heading 2106.

---